Pay in 4 interest-free payments of $6.01 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
Shares of Novo Nordisk fell on Friday after the drugmaker said a late-stage heart drug trial failed to reduce major adverse cardiovascular events, or MACE, compared to a placebo
GLP-1 friendly dinner meals Dinner is where most people on GLP-1 medications face their biggest challenge
GLP-1s in CKD: Evidence, market leadership, and key insights from ASN 2025 At ASN Kidney Week 2025, Glucagon-like peptide-1 (GLP-1) receptor agonists moved firmly into the nephrology spotlight, with more than 70 sessions, posters, and oral abstracts probing their role across the kidney-disease continuum, and even a dedicated mention during the opening plenary talk
These medications carry a boxed warning about thyroid C-cell tumors (contraindicated with personal/family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2) and warnings about potential risks including pancreatitis, gallbladder disease, acute kidney injury with dehydration, and worsening diabetic retinopathy with rapid glucose reduction (particularly with semaglutide)
US$ 21.89
US$ 25.35
US$ 26.99
US$ 20.57
US$ 24.96
US$ 22.20
US$ 27.77
US$ 29.48
